News

Around 388 people with type 2 diabetes previously on diet and exercise were included in the trial, which evaluated the efficacy and safety of 0.5mg and 1.0mg semaglutide

Envarsus XR is an extended release formulation of tacrolimus designed for once-daily dosing, with flatter pharmacokinetics and greater bioavailability compared to twice-daily tacrolimus. The marketing approval is based

Imbruvica is approved in all 28 member states of the European Union (EU) to treat adults with WM who have received at least one prior therapy, or in

Around 150 patients with germinal center diffuse large B cell lymphoma (DLBCL) or follicular lymphoma, stratified into those expressing mutant EZH2 and those expressing wild type EZH2, as

"Bivalirudin has become a foundation anti-thrombin for patients undergoing PCI under The Medicines Company’s fifteen-year leadership in the cath lab," said Glenn Sblendorio, President and Chief Financial Officer,

The transaction will continue to bolster Hi-Tech’s leading Sports Nutrition and Weight Loss arsenal and expand its position as the leader in Diet & Energy products in the

Under the collaboration, Celgene will have the option to license histone methyltransferase (HMT) inhibitors being developed by Epizyme against three predefined targets. Under the terms of the revised

In order to address the need, BARDA, in consultation with the FDA’s Drug Shortage Staff, selected several products from the (FDA) Drug Shortage Index, for the network contractors

EASE LID is a confirmatory trial designed to evaluate the efficacy and safety of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID), a motor complication associated with the